Cargando…

High-density lipoprotein proteome dynamics in human endotoxemia

BACKGROUND: A large variety of proteins involved in inflammation, coagulation, lipid-oxidation and lipid metabolism have been associated with high-density lipoprotein (HDL) and it is anticipated that changes in the HDL proteome have implications for the multiple functions of HDL. Here, SELDI-TOF mas...

Descripción completa

Detalles Bibliográficos
Autores principales: Levels, Johannes HM, Geurts, Pierre, Karlsson, Helen, Marée, Raphaël, Ljunggren, Stefan, Fornander, Louise, Wehenkel, Louis, Lindahl, Mats, Stroes, Erik SG, Kuivenhoven, Jan A, Meijers, Joost CM
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3146904/
https://www.ncbi.nlm.nih.gov/pubmed/21711511
http://dx.doi.org/10.1186/1477-5956-9-34
_version_ 1782209261141491712
author Levels, Johannes HM
Geurts, Pierre
Karlsson, Helen
Marée, Raphaël
Ljunggren, Stefan
Fornander, Louise
Wehenkel, Louis
Lindahl, Mats
Stroes, Erik SG
Kuivenhoven, Jan A
Meijers, Joost CM
author_facet Levels, Johannes HM
Geurts, Pierre
Karlsson, Helen
Marée, Raphaël
Ljunggren, Stefan
Fornander, Louise
Wehenkel, Louis
Lindahl, Mats
Stroes, Erik SG
Kuivenhoven, Jan A
Meijers, Joost CM
author_sort Levels, Johannes HM
collection PubMed
description BACKGROUND: A large variety of proteins involved in inflammation, coagulation, lipid-oxidation and lipid metabolism have been associated with high-density lipoprotein (HDL) and it is anticipated that changes in the HDL proteome have implications for the multiple functions of HDL. Here, SELDI-TOF mass spectrometry (MS) was used to study the dynamic changes of HDL protein composition in a human experimental low-dose endotoxemia model. Ten healthy men with low HDL cholesterol (0.7+/-0.1 mmol/L) and 10 men with high HDL cholesterol levels (1.9+/-0.4 mmol/L) were challenged with endotoxin (LPS) intravenously (1 ng/kg bodyweight). We previously showed that subjects with low HDL cholesterol are more susceptible to an inflammatory challenge. The current study tested the hypothesis that this discrepancy may be related to differences in the HDL proteome. RESULTS: Plasma drawn at 7 time-points over a 24 hour time period after LPS challenge was used for direct capture of HDL using antibodies against apolipoprotein A-I followed by subsequent SELDI-TOF MS profiling. Upon LPS administration, profound changes in 21 markers (adjusted p-value < 0.05) were observed in the proteome in both study groups. These changes were observed 1 hour after LPS infusion and sustained up to 24 hours, but unexpectedly were not different between the 2 study groups. Hierarchical clustering of the protein spectra at all time points of all individuals revealed 3 distinct clusters, which were largely independent of baseline HDL cholesterol levels but correlated with paraoxonase 1 activity. The acute phase protein serum amyloid A-1/2 (SAA-1/2) was clearly upregulated after LPS infusion in both groups and comprised both native and N-terminal truncated variants that were identified by two-dimensional gel electrophoresis and mass spectrometry. Individuals of one of the clusters were distinguished by a lower SAA-1/2 response after LPS challenge and a delayed time-response of the truncated variants. CONCLUSIONS: This study shows that the semi-quantitative differences in the HDL proteome as assessed by SELDI-TOF MS cannot explain why subjects with low HDL cholesterol are more susceptible to a challenge with LPS than those with high HDL cholesterol. Instead the results indicate that hierarchical clustering could be useful to predict HDL functionality in acute phase responses towards LPS.
format Online
Article
Text
id pubmed-3146904
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-31469042011-07-31 High-density lipoprotein proteome dynamics in human endotoxemia Levels, Johannes HM Geurts, Pierre Karlsson, Helen Marée, Raphaël Ljunggren, Stefan Fornander, Louise Wehenkel, Louis Lindahl, Mats Stroes, Erik SG Kuivenhoven, Jan A Meijers, Joost CM Proteome Sci Research BACKGROUND: A large variety of proteins involved in inflammation, coagulation, lipid-oxidation and lipid metabolism have been associated with high-density lipoprotein (HDL) and it is anticipated that changes in the HDL proteome have implications for the multiple functions of HDL. Here, SELDI-TOF mass spectrometry (MS) was used to study the dynamic changes of HDL protein composition in a human experimental low-dose endotoxemia model. Ten healthy men with low HDL cholesterol (0.7+/-0.1 mmol/L) and 10 men with high HDL cholesterol levels (1.9+/-0.4 mmol/L) were challenged with endotoxin (LPS) intravenously (1 ng/kg bodyweight). We previously showed that subjects with low HDL cholesterol are more susceptible to an inflammatory challenge. The current study tested the hypothesis that this discrepancy may be related to differences in the HDL proteome. RESULTS: Plasma drawn at 7 time-points over a 24 hour time period after LPS challenge was used for direct capture of HDL using antibodies against apolipoprotein A-I followed by subsequent SELDI-TOF MS profiling. Upon LPS administration, profound changes in 21 markers (adjusted p-value < 0.05) were observed in the proteome in both study groups. These changes were observed 1 hour after LPS infusion and sustained up to 24 hours, but unexpectedly were not different between the 2 study groups. Hierarchical clustering of the protein spectra at all time points of all individuals revealed 3 distinct clusters, which were largely independent of baseline HDL cholesterol levels but correlated with paraoxonase 1 activity. The acute phase protein serum amyloid A-1/2 (SAA-1/2) was clearly upregulated after LPS infusion in both groups and comprised both native and N-terminal truncated variants that were identified by two-dimensional gel electrophoresis and mass spectrometry. Individuals of one of the clusters were distinguished by a lower SAA-1/2 response after LPS challenge and a delayed time-response of the truncated variants. CONCLUSIONS: This study shows that the semi-quantitative differences in the HDL proteome as assessed by SELDI-TOF MS cannot explain why subjects with low HDL cholesterol are more susceptible to a challenge with LPS than those with high HDL cholesterol. Instead the results indicate that hierarchical clustering could be useful to predict HDL functionality in acute phase responses towards LPS. BioMed Central 2011-06-28 /pmc/articles/PMC3146904/ /pubmed/21711511 http://dx.doi.org/10.1186/1477-5956-9-34 Text en Copyright ©2011 Levels et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Levels, Johannes HM
Geurts, Pierre
Karlsson, Helen
Marée, Raphaël
Ljunggren, Stefan
Fornander, Louise
Wehenkel, Louis
Lindahl, Mats
Stroes, Erik SG
Kuivenhoven, Jan A
Meijers, Joost CM
High-density lipoprotein proteome dynamics in human endotoxemia
title High-density lipoprotein proteome dynamics in human endotoxemia
title_full High-density lipoprotein proteome dynamics in human endotoxemia
title_fullStr High-density lipoprotein proteome dynamics in human endotoxemia
title_full_unstemmed High-density lipoprotein proteome dynamics in human endotoxemia
title_short High-density lipoprotein proteome dynamics in human endotoxemia
title_sort high-density lipoprotein proteome dynamics in human endotoxemia
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3146904/
https://www.ncbi.nlm.nih.gov/pubmed/21711511
http://dx.doi.org/10.1186/1477-5956-9-34
work_keys_str_mv AT levelsjohanneshm highdensitylipoproteinproteomedynamicsinhumanendotoxemia
AT geurtspierre highdensitylipoproteinproteomedynamicsinhumanendotoxemia
AT karlssonhelen highdensitylipoproteinproteomedynamicsinhumanendotoxemia
AT mareeraphael highdensitylipoproteinproteomedynamicsinhumanendotoxemia
AT ljunggrenstefan highdensitylipoproteinproteomedynamicsinhumanendotoxemia
AT fornanderlouise highdensitylipoproteinproteomedynamicsinhumanendotoxemia
AT wehenkellouis highdensitylipoproteinproteomedynamicsinhumanendotoxemia
AT lindahlmats highdensitylipoproteinproteomedynamicsinhumanendotoxemia
AT stroeseriksg highdensitylipoproteinproteomedynamicsinhumanendotoxemia
AT kuivenhovenjana highdensitylipoproteinproteomedynamicsinhumanendotoxemia
AT meijersjoostcm highdensitylipoproteinproteomedynamicsinhumanendotoxemia